+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Microfluidic Devices Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 220 Pages
  • July 2022
  • Region: Global
  • Allied Market Research
  • ID: 5671164
The global microfluidic devices market was valued at $20,971.0 million in 2021, and is projected to reach $158,119.5 million by 2031, registering a CAGR of 22.4% from 2022 to 2031.

Microfluidics is the study of systems that can process small quantities of fluids by using tiny channels having dimensions at the microscale - typically tens to hundreds of micrometers. Microfluidics allows the analysis and use of less volume of samples, chemicals and reagents reducing the global fees of applications.

The increase in prevalence of various infectious diseases such as Flu A, B and diphtheria boosts the growth of the market. Microfluidics are used in the diagnostics of various infectious diseases. In addition, novel approach for the cost-effective diagnosis of tuberculosis further contributes toward the growth of the market. For instance, according to world health organization (WHO), a total of 1.5 million people died from tuberculosis in 2020 worldwide, and tuberculosis is the thirteenth leading cause of death. Thus, increase in prevalence of infectious diseases and rise in use of microfluidics for diagnosis drive the growth of the market.

Moreover, microfluidics are highly sensitive and cost effective which drives the demand for microfluidics devices in diagnosis. In addition, the microfluidics device-based diagnosis requires less quantity of sample and easy product type of operation which boosts the adoption of microfluidics in diagnosis
Furthermore, increase in prevalence of autoimmune disease such as rheumatoid arthritis, scleroderma, and lupus contributes toward the growth of the market. For instance, according to global RA network, approximately 350 million people have arthritis globally. Arthritis, or joint disease, is inflammation of one or more of the joints, such as the knees, knuckles, wrists, or ankles. Arthritis starts as joint inflammation but can progress into joint pain, swelling, and stiffness. A microfluidic chip was recently developed to detect autoimmune diseases. The device measures the number of specified antibodies in the blood.

Moreover, increase in R&D activities for development of advanced microfluidics device such as 3D printing & robotics, rise in U.S. food and drug administration (USFDA) approvals and novel product launch in the market by key players boost the market growth. For instance, in December 2020, Conformis, Inc., a leader in patient-specific knee and hip instrumentation and implants, announced today the U.S. commercial launch of the Company’s new Cordera Match Hip System. Furthermore, advancements in microfluidics devices such as robotics and navigation support further contribute toward the market growth. However, high cost of microfluidics devices and product recall are anticipated to hinder the growth of the market.

The microfluidics device market is segmented on the basis of product type, application, end user and region. By product type, the market is divided into microfluidic-based devices and microfluidic components. The microfluidic components segment is classified into microfluidic chips, flow & pressure sensors, flow & pressure controllers, microfluidic valves, micropumps, microneedles and other components.

Depending on application, the market is classified into in-vitro diagnostics, pharmaceutical & life science research & manufacturing and therapeutics. The in-vitro diagnostics segment is further classified into clinical diagnostics, point-of-care testing and veterinary diagnostics. The pharmaceutical & life science research & manufacturing and therapeutics segment is further classified into lab analytics, microdispensing and microreaction. The lab analytics segment is further categorized into proteomics, genomics, cell-based assays and capillary electrophoresis.

The therapeutics segment is further classified into drug delivery and wearable devices.

Based on end user, the market is categorized into hospitals & diagnostic centers, academic & research institutes, and pharmaceutical & biotechnology companies. By region segment, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Lonza Group, Thermo Fisher Scientific Inc., Perkinelmer Inc., Biorad Laboratories, Inc., Illumina, Inc., Qiagen N.V., Fluidigm Corporation, Dolomite Microfluidics, bioMérieux SA, Abbott Laboratories, Danaher Corporation, SMC Corporation, Idex Corporation, Fortive Corporation, Agilent Technologies, Inc., Nanostring and Nortis Inc.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the microfluidic devices market analysis from 2021 to 2031 to identify the prevailing microfluidic devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the microfluidic devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global microfluidic devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Microfluidic-based Devices
  • Microfluidic Components
  • Type
  • Microfluidic Chips
  • Flow Pressure Sensors
  • Flow Pressure Controllers
  • Microfluidic Valves
  • Micropumps
  • Microneedles
  • Other Components

By Application

  • In-vitro Diagnostics
  • Type
  • Clinical Diagnostics
  • Point-of-care Testing
  • Veterinary Diagnostics
  • Pharmaceutical Life Science Research and Manufacturing
  • Type
  • Lab Analytics
  • Microdispensing
  • Microreaction
  • Therapeutics
  • Type
  • Drug Delivery
  • Wearable Devices

By End User

  • Hospitals Diagnostic Centers
  • Academic Research Institutes
  • Pharmaceutical Biotechnology Companies

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Soudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Lonza Group
  • Thermo Fisher Scientific Inc.
  • Perkinelmer Inc.
  • Biorad Laboratories, Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Fluidigm Corporation
  • Dolomite Microfluidics
  • bioMérieux SA
  • Abbott Laboratories
  • Danaher Corporation
  • SMC Corporation
  • Idex Corporation
  • Fortive Corporation
  • Agilent Technologies, Inc.
  • Nanostring
  • Nortis Inc.
Frequently Asked Questions about the Global Microfluidic Devices Market

What is the estimated value of the Global Microfluidic Devices Market?

The Global Microfluidic Devices Market was estimated to be valued at $20971 million in 2021.

What is the growth rate of the Global Microfluidic Devices Market?

The growth rate of the Global Microfluidic Devices Market is 22.4%, with an estimated value of $158119.5 million by 2031.

What is the forecasted size of the Global Microfluidic Devices Market?

The Global Microfluidic Devices Market is estimated to be worth $158119.5 million by 2031.

Who are the key companies in the Global Microfluidic Devices Market?

Key companies in the Global Microfluidic Devices Market include Lonza Group, Thermo Fisher Scientific Inc., Perkinelmer Inc., Biorad Laboratories, Inc., Illumina, Inc., Qiagen N.V., Fluidigm Corporation, Dolomite Microfluidics, Biomérieux Sa and Abbott Laboratories.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: MICROFLUIDIC DEVICES MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Microfluidic-based Devices
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Microfluidic Components
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.3.4 Microfluidic Components Microfluidic Devices Market by Type
4.3.4.1 Microfluidic Chips Market size and forecast, by region
4.3.4.2 Flow & Pressure Sensors Market size and forecast, by region
4.3.4.3 Flow & Pressure Controllers Market size and forecast, by region
4.3.4.4 Microfluidic Valves Market size and forecast, by region
4.3.4.5 Micropumps Market size and forecast, by region
4.3.4.6 Microneedles Market size and forecast, by region
4.3.4.7 Other Components Market size and forecast, by region
CHAPTER 5: MICROFLUIDIC DEVICES MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 In-vitro Diagnostics
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 In-vitro Diagnostics Microfluidic Devices Market by Type
5.2.4.1 Clinical Diagnostics Market size and forecast, by region
5.2.4.2 Point-of-care Testing Market size and forecast, by region
5.2.4.3 Veterinary Diagnostics Market size and forecast, by region
5.3 Pharmaceutical & Life Science Research and Manufacturing
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.3.4 Pharmaceutical & Life Science Research and Manufacturing Microfluidic Devices Market by Type
5.3.4.1 Lab Analytics Market size and forecast, by region
5.3.4.2 Microdispensing Market size and forecast, by region
5.3.4.3 Microreaction Market size and forecast, by region
5.4 Therapeutics
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.4.4 Therapeutics Microfluidic Devices Market by Type
5.4.4.1 Drug Delivery Market size and forecast, by region
5.4.4.2 Wearable Devices Market size and forecast, by region
CHAPTER 6: MICROFLUIDIC DEVICES MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals & Diagnostic Centers
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Academic & Research Institutes
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Pharmaceutical & Biotechnology Companies
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: MICROFLUIDIC DEVICES MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.2.1 North America Microfluidic Components Microfluidic Devices Market by Type
7.2.3 North America Market size and forecast, by Application
7.2.3.1 North America In-vitro Diagnostics Microfluidic Devices Market by Type
7.2.3.2 North America Pharmaceutical & Life Science Research and Manufacturing Microfluidic Devices Market by Type
7.2.3.3 North America Therapeutics Microfluidic Devices Market by Type
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.2.1 Europe Microfluidic Components Microfluidic Devices Market by Type
7.3.3 Europe Market size and forecast, by Application
7.3.3.1 Europe In-vitro Diagnostics Microfluidic Devices Market by Type
7.3.3.2 Europe Pharmaceutical & Life Science Research and Manufacturing Microfluidic Devices Market by Type
7.3.3.3 Europe Therapeutics Microfluidic Devices Market by Type
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.2.1 Asia-Pacific Microfluidic Components Microfluidic Devices Market by Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.3.1 Asia-Pacific In-vitro Diagnostics Microfluidic Devices Market by Type
7.4.3.2 Asia-Pacific Pharmaceutical & Life Science Research and Manufacturing Microfluidic Devices Market by Type
7.4.3.3 Asia-Pacific Therapeutics Microfluidic Devices Market by Type
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.2.1 LAMEA Microfluidic Components Microfluidic Devices Market by Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.3.1 LAMEA In-vitro Diagnostics Microfluidic Devices Market by Type
7.5.3.2 LAMEA Pharmaceutical & Life Science Research and Manufacturing Microfluidic Devices Market by Type
7.5.3.3 LAMEA Therapeutics Microfluidic Devices Market by Type
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Soudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Lonza Group
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Thermo Fisher Scientific Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Perkinelmer Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Biorad Laboratories, Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Illumina, Inc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Qiagen N.V.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Fluidigm Corporation
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Dolomite Microfluidics
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 bioMérieux SA
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Abbott Laboratories
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 Danaher Corporation
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 SMC Corporation
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
9.13 Idex Corporation
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Operating business segments
9.13.4 Product portfolio
9.13.5 Business performance
9.13.6 Key strategic moves and developments
9.14 Fortive Corporation
9.14.1 Company overview
9.14.2 Company snapshot
9.14.3 Operating business segments
9.14.4 Product portfolio
9.14.5 Business performance
9.14.6 Key strategic moves and developments
9.15 Agilent Technologies, Inc.
9.15.1 Company overview
9.15.2 Company snapshot
9.15.3 Operating business segments
9.15.4 Product portfolio
9.15.5 Business performance
9.15.6 Key strategic moves and developments
9.16 Nanostring
9.16.1 Company overview
9.16.2 Company snapshot
9.16.3 Operating business segments
9.16.4 Product portfolio
9.16.5 Business performance
9.16.6 Key strategic moves and developments
9.17 Nortis Inc.
9.17.1 Company overview
9.17.2 Company snapshot
9.17.3 Operating business segments
9.17.4 Product portfolio
9.17.5 Business performance
9.17.6 Key strategic moves and developments
List of Tables
Table 1. Global Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 2. Lactose Free Dairy Market Revenue, for Milk, by Region , 2021-2031,($Million)
Table 3. Lactose Free Dairy Market for Milk by Country, 2021-2031,($Million)
Table 4. Lactose Free Dairy Market Revenue, for Cheese, by Region , 2021-2031,($Million)
Table 5. Lactose Free Dairy Market for Cheese by Country, 2021-2031,($Million)
Table 6. Lactose Free Dairy Market Revenue, for Yogurt, by Region , 2021-2031,($Million)
Table 7. Lactose Free Dairy Market for Yogurt by Country, 2021-2031,($Million)
Table 8. Lactose Free Dairy Market Revenue, for Others, by Region , 2021-2031,($Million)
Table 9. Lactose Free Dairy Market for Others by Country, 2021-2031,($Million)
Table 10. Global Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 11. Lactose Free Dairy Market Revenue, for Solid, by Region , 2021-2031,($Million)
Table 12. Lactose Free Dairy Market for Solid by Country, 2021-2031,($Million)
Table 13. Lactose Free Dairy Market Revenue, for Liquid, by Region , 2021-2031,($Million)
Table 14. Lactose Free Dairy Market for Liquid by Country, 2021-2031,($Million)
Table 15. Lactose Free Dairy Market Revenue, for Powder, by Region , 2021-2031,($Million)
Table 16. Lactose Free Dairy Market for Powder by Country, 2021-2031,($Million)
Table 17. Global Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 18. Lactose Free Dairy Market Revenue, for Hypermarkets/Supermarkets, by Region , 2021-2031,($Million)
Table 19. Lactose Free Dairy Market for Hypermarkets/Supermarkets by Country, 2021-2031,($Million)
Table 20. Lactose Free Dairy Market Revenue, for Convenience Stores, by Region , 2021-2031,($Million)
Table 21. Lactose Free Dairy Market for Convenience Stores by Country, 2021-2031,($Million)
Table 22. Lactose Free Dairy Market Revenue, for Online Channels, by Region , 2021-2031,($Million)
Table 23. Lactose Free Dairy Market for Online Channels by Country, 2021-2031,($Million)
Table 24. Lactose Free Dairy Market Revenue, for Others, by Region , 2021-2031,($Million)
Table 25. Lactose Free Dairy Market for Others by Country, 2021-2031,($Million)
Table 26. Lactose Free Dairy Market, by Region, 2021-2031,($Million)
Table 27. North America Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 28. North America Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 29. North America Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 30. North America Lactose Free Dairy Market, by Country, 2021-2031,($Million)
Table 31. U.S. Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 32. U.S. Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 33. U.S. Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 34. Canada Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 35. Canada Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 36. Canada Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 37. Mexico Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 38. Mexico Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 39. Mexico Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 40. Europe Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 41. Europe Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 42. Europe Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 43. Europe Lactose Free Dairy Market, by Country, 2021-2031,($Million)
Table 44. Germany Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 45. Germany Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 46. Germany Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 47. U.K. Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 48. U.K. Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 49. U.K. Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 50. France Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 51. France Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 52. France Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 53. Italy Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 54. Italy Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 55. Italy Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 56. Spain Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 57. Spain Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 58. Spain Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 59. Rest of Europe Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 60. Rest of Europe Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 61. Rest of Europe Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 62. Asia-Pacific Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 63. Asia-Pacific Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 64. Asia-Pacific Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 65. Asia-Pacific Lactose Free Dairy Market, by Country, 2021-2031,($Million)
Table 66. China Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 67. China Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 68. China Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 69. India Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 70. India Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 71. India Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 72. Japan Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 73. Japan Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 74. Japan Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 75. Australia Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 76. Australia Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 77. Australia Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 78. South Korea Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 79. South Korea Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 80. South Korea Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 81. Rest of Asia-Pacific Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 82. Rest of Asia-Pacific Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 83. Rest of Asia-Pacific Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 84. LAMEA Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 85. LAMEA Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 86. LAMEA Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 87. LAMEA Lactose Free Dairy Market, by Country, 2021-2031,($Million)
Table 88. Brazil Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 89. Brazil Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 90. Brazil Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 91. Turkey Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 92. Turkey Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 93. Turkey Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 94. South Africa Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 95. South Africa Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 96. South Africa Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 97. Argentina Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 98. Argentina Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 99. Argentina Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 100. Rest of LAMEA Lactose Free Dairy Market, by Type, 2021-2031,($Million)
Table 101. Rest of LAMEA Lactose Free Dairy Market, by Form, 2021-2031,($Million)
Table 102. Rest of LAMEA Lactose Free Dairy Market, by Distribution Channel, 2021-2031,($Million)
Table 103. Arla Foods Amba: Company Snapshot
Table 104. Arla Foods Amba: Operating Segments
Table 105. Arla Foods Amba: Product Portfolio
Table 106. Arla Foods Amba: Net Sales
Table 107. Arla Foods Amba: Key Stratergies
Table 108. Danone S.A.: Company Snapshot
Table 109. Danone S.A.: Operating Segments
Table 110. Danone S.A.: Product Portfolio
Table 111. Danone S.A.: Net Sales
Table 112. Danone S.A.: Key Stratergies
Table 113. General Mills, Inc.: Company Snapshot
Table 114. General Mills, Inc.: Operating Segments
Table 115. General Mills, Inc.: Product Portfolio
Table 116. General Mills, Inc.: Net Sales
Table 117. General Mills, Inc.: Key Stratergies
Table 118. Gujrat Cooperative Milk Marketing Federation (Amul): Company Snapshot
Table 119. Gujrat Cooperative Milk Marketing Federation (Amul): Operating Segments
Table 120. Gujrat Cooperative Milk Marketing Federation (Amul): Product Portfolio
Table 121. Gujrat Cooperative Milk Marketing Federation (Amul): Net Sales
Table 122. Gujrat Cooperative Milk Marketing Federation (Amul): Key Stratergies
Table 123. Johnson & Johnson Services, Inc.: Company Snapshot
Table 124. Johnson & Johnson Services, Inc.: Operating Segments
Table 125. Johnson & Johnson Services, Inc.: Product Portfolio
Table 126. Johnson & Johnson Services, Inc.: Net Sales
Table 127. Johnson & Johnson Services, Inc.: Key Stratergies
Table 128. Lifeway Foods, Inc.: Company Snapshot
Table 129. Lifeway Foods, Inc.: Operating Segments
Table 130. Lifeway Foods, Inc.: Product Portfolio
Table 131. Lifeway Foods, Inc.: Net Sales
Table 132. Lifeway Foods, Inc.: Key Stratergies
Table 133. Nestle S.A.: Company Snapshot
Table 134. Nestle S.A.: Operating Segments
Table 135. Nestle S.A.: Product Portfolio
Table 136. Nestle S.A.: Net Sales
Table 137. Nestle S.A.: Key Stratergies
Table 138. Organic Valley: Company Snapshot
Table 139. Organic Valley: Operating Segments
Table 140. Organic Valley: Product Portfolio
Table 141. Organic Valley: Net Sales
Table 142. Organic Valley: Key Stratergies
Table 143. Saputo, Inc.: Company Snapshot
Table 144. Saputo, Inc.: Operating Segments
Table 145. Saputo, Inc.: Product Portfolio
Table 146. Saputo, Inc.: Net Sales
Table 147. Saputo, Inc.: Key Stratergies
Table 148. The Kroger Company: Company Snapshot
Table 149. The Kroger Company: Operating Segments
Table 150. The Kroger Company: Product Portfolio
Table 151. The Kroger Company: Net Sales
Table 152. The Kroger Company: Key Stratergies
List of Figures
Figure 1. Microfluidic Devices Market Segmentation
Figure 2. Microfluidic Devices Market,2021-2031
Figure 3. Microfluidic Devices Market,2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Microfluidic Devices Market:Drivers, Restraints and Opportunities
Figure 12. Microfluidic Devices Market,By Product,2021(%)
Figure 13. Comparative Share Analysis of Microfluidic-based Devices Microfluidic Devices Market,2021-2031(%)
Figure 14. Comparative Share Analysis of Microfluidic Components Microfluidic Devices Market,2021-2031(%)
Figure 15. Microfluidic Devices Market,By Application,2021(%)
Figure 16. Comparative Share Analysis of In-Vitro Diagnostics Microfluidic Devices Market,2021-2031(%)
Figure 17. Comparative Share Analysis of Pharmaceutical & Life Science Research and Manufacturing Microfluidic Devices Market,2021-2031(%)
Figure 18. Comparative Share Analysis of Therapeutics Microfluidic Devices Market,2021-2031(%)
Figure 19. Microfluidic Devices Market,By End-user,2021(%)
Figure 20. Comparative Share Analysis of Hospitals & Diagnostic Centers Microfluidic Devices Market,2021-2031(%)
Figure 21. Comparative Share Analysis of Academic & Research Institutes Microfluidic Devices Market,2021-2031(%)
Figure 22. Comparative Share Analysis of Pharmaceutical & Biotechnology Companies Microfluidic Devices Market,2021-2031(%)
Figure 23. Microfluidic Devices Market by Region,2021
Figure 24. U.S. Microfluidic Devices Market,2021-2031($Million)
Figure 25. Canada Microfluidic Devices Market,2021-2031($Million)
Figure 26. Mexico Microfluidic Devices Market,2021-2031($Million)
Figure 27. Germany Microfluidic Devices Market,2021-2031($Million)
Figure 28. France Microfluidic Devices Market,2021-2031($Million)
Figure 29. Uk Microfluidic Devices Market,2021-2031($Million)
Figure 30. Italy Microfluidic Devices Market,2021-2031($Million)
Figure 31. Spain Microfluidic Devices Market,2021-2031($Million)
Figure 32. Rest of Europe Microfluidic Devices Market,2021-2031($Million)
Figure 33. China Microfluidic Devices Market,2021-2031($Million)
Figure 34. Japan Microfluidic Devices Market,2021-2031($Million)
Figure 35. India Microfluidic Devices Market,2021-2031($Million)
Figure 36. Australia Microfluidic Devices Market,2021-2031($Million)
Figure 37. South Korea Microfluidic Devices Market,2021-2031($Million)
Figure 38. Rest of Asia-Pacific Microfluidic Devices Market,2021-2031($Million)
Figure 39. Brazil Microfluidic Devices Market,2021-2031($Million)
Figure 40. Soudi Arabia Microfluidic Devices Market,2021-2031($Million)
Figure 41. South Africa Microfluidic Devices Market,2021-2031($Million)
Figure 42. Rest of LAMEA Microfluidic Devices Market,2021-2031($Million)
Figure 43. Top Winning Strategies, by Year
Figure 44. Top Winning Strategies, by Development
Figure 45. Top Winning Strategies, by Company
Figure 46. Product Mapping of Top 10 Players
Figure 47. Competitive Dashboard
Figure 48. Competitive Heatmap of Top 10 Key Players
Figure 49. Lonza Group.: Net Sales ,($Million)
Figure 50. Thermo Fisher Scientific Inc..: Net Sales ,($Million)
Figure 51. Perkinelmer Inc..: Net Sales ,($Million)
Figure 52. Biorad Laboratories, Inc..: Net Sales ,($Million)
Figure 53. Illumina, Inc..: Net Sales ,($Million)
Figure 54. Qiagen N.V..: Net Sales ,($Million)
Figure 55. Fluidigm Corporation.: Net Sales ,($Million)
Figure 56. Dolomite Microfluidics.: Net Sales ,($Million)
Figure 57. Biomérieux SA.: Net Sales ,($Million)
Figure 58. Abbott Laboratories.: Net Sales ,($Million)
Figure 59. Danaher Corporation.: Net Sales ,($Million)
Figure 60. Smc Corporation.: Net Sales ,($Million)
Figure 61. Idex Corporation.: Net Sales ,($Million)
Figure 62. Fortive Corporation.: Net Sales ,($Million)
Figure 63. Agilent Technologies, Inc..: Net Sales ,($Million)
Figure 64. Nanostring.: Net Sales ,($Million)
Figure 65. Nortis Inc..: Net Sales ,($Million)

Executive Summary

According to the report, titled, “Microfluidic Devices Market," the microfluidic devices market was valued at $21 billion in 2021, and is estimated to reach $158.1 billion by 2031, growing at a CAGR of 22.4% from 2021 to 2031.

Microfluidic devices exploit the physical and chemical properties of liquids and gases at a microscale. Microfluidic devices offer several benefits over conventionally sized systems. Microfluidics allow the analysis and use of less volume of samples, chemicals and reagents reducing the global fees of applications.

The increase in prevalence of infectious diseases and cancer drives the growth of the Microfluidic Devices Market. Microfluidics devices are used for the diagnosis of infectious diseases. For instance, according to World Health Organization (WHO), cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The microfluidics platforms are being used to detect genetic mutations that correspond to breast cancer, including DNA and miRNA mutations. Microfluidics platforms are able to analyze more sample volume in a shorter amount of time than traditional detection methods owing to their high throughput and low time requirements.

Furthermore, rise in number of geriatric populations boosts the growth of the Microfluidic Devices Market size. Old age people are more prone to infectious diseases and cancer. Thus, geriatric population signifies increase in patients of chronic diseases. For instance, according to World Health Organization (WHO), by 2050, the world’s population of people aged 60 years and older will reached to 2.1 billion.

Advancement in technology by key players for the development and manufacturing of microfluidic device contributes to drive the growth of the Microfluidic Industry. Increase in the awareness regarding use of micro pump in medical device and effectiveness of microfluidic components in drug delivery system cause rise in the demand of microfluidic system in biomedical industry. Thus, this factor is anticipated to drive the market growth. Moreover, increase in number of pharmaceutical and biotechnology companies cause rise in the demand for micro pump which boosts the market growth
Furthermore, Microfluidic Devices Market trends that drive the Microfluidic Devices Market growth include R&D for development of microfluidics device, increase in product type approvals, and new product launched in market. For instance, in November 2021, Fluidigm Corporation, a biotechnology tools provider with a vision to improve life through comprehensive health insight, has announced the launch of Biomark X, the latest generation of its Biomark microfluidics platform. Biomark X integrates the Fluidigm Juno and Biomark HD instruments into a single platform while adding an expansive set of sample-to-answer capabilities on a single versatile, scalable and transformative genomics platform. Furthermore, the rise in healthcare expenditure and improvements in healthcare facilities in developing nations contributes towards growth of the microfluidics device market.

The microfluidics device market is segmented into by product type, application, end user, and region.

On the basis of product type, the market is divided into microfluidic-based devices and microfluidic components. The microfluidic components segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to growing demand for microfluidics devices and rise in adoption of microfluidics in diagnosis & drug delivery.

On the basis of application, the market is categorized into in-vitro diagnostics, pharmaceutical & life science research & manufacturing and therapeutics. The in-vitro diagnostics segment dominated the Microfluidic Devices Market share in 2021, and this trend is expected to continue during the forecast period, owing to increase in prevalence of infectious diseases and autoimmune diseases.

On the basis of end user, the market is classified into hospitals & diagnostic centers, academic & research institutes and pharmaceutical & biotechnology companies. The hospitals & diagnostic centers segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to growing application in diagnosis of infectious diseases and rise in healthcare expenditures.

North America accounted for a majority of the global microfluidics device market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of infectious diseases, well established healthcare infrastructure and presence of key players in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in incidences of cancer, growing geriatric population and high population base.

Key Findings of the Study

  • On the basis of product type, the microfluidic components segment was the highest contributor to the market in 2021.
  • On the basis of application, the in-vitro diagnostics segment was the highest contributor to the market in 2021.
  • On the basis of end user, the hospitals & diagnostic centers segment was the highest contributor to the market in 2021.
  • On the basis of region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period

Companies Mentioned

  • Lonza Group
  • Thermo Fisher Scientific Inc.
  • Perkinelmer Inc.
  • Biorad Laboratories, Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Fluidigm Corporation
  • Dolomite Microfluidics
  • Biomérieux Sa
  • Abbott Laboratories
  • Danaher Corporation
  • Smc Corporation
  • Idex Corporation
  • Fortive Corporation
  • Agilent Technologies, Inc.
  • Nanostring
  • Nortis Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...